-+ 0.00%
-+ 0.00%
-+ 0.00%

Orchestra BioMed CEO, Chair David Hochman buys 5,000 shares for $18,850

PUBT·05/19/2026 12:01:23
Listen to the news
Orchestra BioMed CEO, Chair David Hochman buys 5,000 shares for $18,850
  • David P. Hochman, chief executive officer and chairperson of Orchestra BioMed, bought 5,000 common shares at a weighted-average price of $3.77.
  • His directly held stake rose to 1,059,029 shares following the purchase.
  • He also reported indirect ownership of 448,622 shares held through family trusts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-063510), on May 19, 2026, and is solely responsible for the information contained therein.